|
1
|
Germano I, Swiss V and Casaccia P: Primary
brain tumors, neural stem cell, and brain tumor cancer cells: Where
is the link? Neuropharmacology. 58:903–910. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bianco C, Strizzi L, Normanno N, Khan N
and Salomon DS: Cripto-1: An oncofetal gene with many faces. Curr
Top Dev Biol. 67:85–133. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Strizzi L, Bianco C, Normanno N and
Salomon D: Cripto-1: A multifunctional modulator during
embryogenesis and oncogenesis. Oncogene. 24:5731–5741. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
De Luca A, Lamura L, Strizzi L, Roma C,
D'Antonio A, Margaryan N, Pirozzi G, Hsu MY, Botti G, Mari E, et
al: Expression and functional role of CRIPTO-1 in cutaneous
melanoma. Br J Cancer. 105:1030–1038. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yoon HJ, Hong JS, Shin WJ, Lee YJ, Hong
KO, Lee JI, Hong SP and Hong SD: The role of Cripto-1 in the
tumorigenesis and progression of oral squamous cell carcinoma. Oral
Oncol. 47:1023–1031. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Normanno N, De Luca A, Bianco C, Maiello
MR, Carriero MV, Rehman A, Wechselberger C, Arra C, Strizzi L,
Sanicola M, et al: Cripto-1 overexpression leads to enhanced
invasiveness and resistance to anoikis in human MCF-7 breast cancer
cells. J Cell Physiol. 198:31–39. 2004. View Article : Google Scholar
|
|
7
|
Wu Z, Li G, Wu L, Weng D, Li X and Yao K:
Cripto-1 overexpression is involved in the tumorigenesis of
nasopharyngeal carcinoma. BMC Cancer. 9:3152009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pilgaard L, Mortensen JH, Henriksen M,
Olesen P, Sørensen P, Laursen R, Vyberg M, Agger R, Zachar V, Moos
T, et al: Cripto-1 expression in glioblastoma multiforme. Brain
Pathol. 24:360–370. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tysnes BB, Satran HA, Mork SJ, Margaryan
NV, Eide GE, Petersen K, Strizzi L and Hendrix MJ: Age-dependent
association between protein expression of the embryonic stem cell
marker cripto-1 and survival of glioblastoma patients. Transl
Oncol. 6:732–741. 2013. View Article : Google Scholar
|
|
10
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cimmino A, Calin GA, Fabbri M, Iorio MV,
Ferracin M, Shimizu M, Wojcik SE, Aqeilan RI, Zupo S, Dono M, et
al: miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl
Acad Sci USA. 102:13944–13949. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bonci D, Coppola V, Musumeci M, Addario A,
Giuffrida R, Memeo L, D'Urso L, Pagliuca A, Biffoni M, Labbaye C,
et al: The miR-15a-miR-16-1 cluster controls prostate cancer by
targeting multiple oncogenic activities. Nat Med. 14:1271–1277.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Baraniskin A, Kuhnhenn J, Schlegel U,
Maghnouj A, Zöllner H, Schmiegel W, Hahn S and Schroers R:
Identification of microRNAs in the cerebrospinal fluid as biomarker
for the diagnosis of glioma. Neuro-oncol. 14:29–33. 2012.
View Article : Google Scholar :
|
|
14
|
Xia L, Zhang D, Du R, Pan Y, Zhao L, Sun
S, Hong L, Liu J and Fan D: miR-15b and miR-16 modulate multidrug
resistance by targeting BCL2 in human gastric cancer cells. Int J
Cancer. 123:372–379. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sun G, Yan S, Shi L, Wan Z, Jiang N, Li M
and Guo J: Decreased expression of miR-15b in human gliomas is
associated with poor prognosis. Cancer Biother Radiopharm.
30:169–173. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
17
|
Giese A, Bjerkvig R, Berens ME and
Westphal M: Cost of migration: Invasion of malignant gliomas and
implications for treatment. J Clin Oncol. 21:1624–1636. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Furnari FB, Fenton T, Bachoo RM, Mukasa A,
Stommel JM, Stegh A, Hahn WC, Ligon KL, Louis DN, Brennan C, et al:
Malignant astrocytic glioma: Genetics, biology, and paths to
treatment. Genes Dev. 21:2683–2710. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Van Meir EG, Hadjipanayis CG, Norden AD,
Shu HK, Wen PY and Olson JJ: Exciting new advances in
neuro-oncology: The avenue to a cure for malignant glioma. CA
Cancer J Clin. 60:166–193. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhong XY, Zhang LH, Jia SQ, Shi T, Niu ZJ,
Du H, Zhang GG, Hu Y, Lu AP, Li JY, et al: Positive association of
up-regulated Cripto-1 and down-regulated E-cadherin with tumour
progression and poor prognosis in gastric cancer. Histopathology.
52:560–568. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gong YP, Yarrow PM, Carmalt HL, Kwun SY,
Kennedy CW, Lin BP, Xing PX and Gillett DJ: Overexpression of
Cripto and its prognostic significance in breast cancer: A study
with long-term survival. Eur J Surg Oncol. 33:438–443. 2007.
View Article : Google Scholar
|
|
22
|
Adkins HB, Bianco C, Schiffer SG, Rayhorn
P, Zafari M, Cheung AE, Orozco O, Olson D, De Luca A, Chen LL, et
al: Antibody blockade of the Cripto CFC domain suppresses tumor
cell growth in vivo. J Clin Invest. 112:575–587. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Strizzi L, Bianco C, Normanno N, Seno M,
Wechselberger C, Wallace-Jones B, Khan NI, Hirota M, Sun Y,
Sanicola M, et al: Epithelial mesenchymal transition is a
characteristic of hyperplasias and tumors in mammary gland from
MMTV-Cripto-1 transgenic mice. J Cell Physiol. 201:266–276. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lee YS and Dutta A: MicroRNAs in cancer.
Annu Rev Pathol. 4:199–227. 2009. View Article : Google Scholar :
|
|
25
|
Schwarzenbach H, Nishida N, Calin GA and
Pantel K: Clinical relevance of circulating cell-free microRNAs in
cancer. Nat Rev Clin Oncol. 11:145–156. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sun G, Shi L, Yan S, Wan Z, Jiang N, Fu L,
Li M and Guo J: MiR-15b targets cyclin D1 to regulate proliferation
and apoptosis in glioma cells. BioMed Res Int. 2014:6878262014.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xia H, Qi Y, Ng SS, Chen X, Chen S, Fang
M, Li D, Zhao Y, Ge R, Li G, et al: MicroRNA-15b regulates cell
cycle progression by targeting cyclins in glioma cells. Biochem
Biophys Res Commun. 380:205–210. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zheng X, Chopp M, Lu Y, Buller B and Jiang
F: MiR-15b and miR-152 reduce glioma cell invasion and angiogenesis
via NRP-2 and MMP-3. Cancer Lett. 329:146–154. 2013. View Article : Google Scholar :
|
|
29
|
Wu CS, Yen CJ, Chou RH, Chen JN, Huang WC,
Wu CY and Yu YL: Downregulation of microRNA-15b by hepatitis B
virus X enhances hepatocellular carcinoma proliferation via
fucosyltransferase 2-induced Globo H expression. Int J Cancer.
134:1638–1647. 2014. View Article : Google Scholar
|
